SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-22-003383
Filing Date
2022-06-22
Accepted
2022-06-22 16:17:58
Documents
1
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3942
  Complete submission text file 0001179110-22-003383.txt   5610
Mailing Address 10 FINDERNE AVENUE BRIDGEWATER NJ 08807
Business Address
Pellizzari Christine A (Reporting) CIK: 0001127430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 221032271

Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations